Diaceutics DIUXF Stock
Diaceutics Price Chart
Diaceutics DIUXF Financial and Trading Overview
| Diaceutics stock price | 2.31 USD |
| Previous Close | 2.31 USD |
| Open | 2 USD |
| Bid | 2.08 USD x 10000 |
| Ask | 2.77 USD x 10000 |
| Day's Range | 2 - 2 USD |
| 52 Week Range | 1.37 - 2.51 USD |
| Volume | 3.5K USD |
| Avg. Volume | 55 USD |
| Market Cap | 195.76M USD |
| Beta (5Y Monthly) | 0.884 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DIUXF Valuation Measures
| Enterprise Value | 189.39M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.7366624 |
| Price/Book (mrq) | 3.8148012 |
| Enterprise Value/Revenue | 4.583 |
| Enterprise Value/EBITDA | 49.091 |
Trading Information
Diaceutics Stock Price History
| Beta (5Y Monthly) | 0.884 |
| 52-Week Change | 68.66% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 2.51 USD |
| 52 Week Low | 1.37 USD |
| 50-Day Moving Average | 2.04 USD |
| 200-Day Moving Average | 1.81 USD |
DIUXF Share Statistics
| Avg. Volume (3 month) | 55 USD |
| Avg. Daily Volume (10-Days) | 350 USD |
| Shares Outstanding | 84.89M |
| Float | 48.83M |
| Short Ratio | N/A |
| % Held by Insiders | 27.81% |
| % Held by Institutions | 64.33% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -0.65% |
| Operating Margin (ttm) | -23.0060% |
| Gross Margin | 82.87% |
| EBITDA Margin | 9.33% |
Management Effectiveness
| Return on Assets (ttm) | -1.028% |
| Return on Equity (ttm) | -0.71% |
Income Statement
| Revenue (ttm) | 41.33M USD |
| Revenue Per Share (ttm) | 0.49 USD |
| Quarterly Revenue Growth (yoy) | 19.90% |
| Gross Profit (ttm) | 34.25M USD |
| EBITDA | 3.86M USD |
| Net Income Avi to Common (ttm) | -271000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.1M USD |
| Total Cash Per Share (mrq) | 0.1 USD |
| Total Debt (mrq) | 2.09M USD |
| Total Debt/Equity (mrq) | 5.4 USD |
| Current Ratio (mrq) | 2.555 |
| Book Value Per Share (mrq) | 0.6044876 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.92M USD |
| Levered Free Cash Flow (ttm) | -449625 USD |
Profile of Diaceutics
| Country | United States |
| State | N/A |
| City | Belfast |
| Address | Building Two |
| ZIP | BT9 6GW |
| Phone | N/A |
| Website | https://www.diaceutics.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 205 |
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Q&A For Diaceutics Stock
What is a current DIUXF stock price?
Diaceutics DIUXF stock price today per share is 2.31 USD.
How to purchase Diaceutics stock?
You can buy DIUXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diaceutics?
The stock symbol or ticker of Diaceutics is DIUXF.
Which industry does the Diaceutics company belong to?
The Diaceutics industry is Health Information Services.
How many shares does Diaceutics have in circulation?
The max supply of Diaceutics shares is 84.89M.
What is Diaceutics Price to Earnings Ratio (PE Ratio)?
Diaceutics PE Ratio is now.
What was Diaceutics earnings per share over the trailing 12 months (TTM)?
Diaceutics EPS is 0 USD over the trailing 12 months.
Which sector does the Diaceutics company belong to?
The Diaceutics sector is Healthcare.
